copy of dr. o’shaughnessy on clinical implications of the text and soft trials in breast cancer
Published 5 years ago • 56 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:32
dr. o’shaughnessy on clinical implications of the text and soft trials in breast cancer
-
1:22
dr. o'shaughnessy on the utility of capivasertib in targeting akt in breast cancer
-
1:40
dr. o'shaughnessy on the future of breast cancer biomarkers
-
1:35
dr. o'shaughnessy on the future of breast cancer treatment
-
1:07
dr. o'shaughnessy on avastin as her standard of care
-
1:51
dr. o'shaughnessy on breast cancer subtype-specific cytotoxic agents
-
1:03
dr. o'shaughnessy on the future of tnbc treatment
-
1:59:33
addressing current questions and controversies in the management of metastatic breast cancer
-
14:21
genomic testing during breast cancer: should you have testing?
-
1:14:37
individualizing the selection of first-line therapy for patients with hr-positive metastatic bc
-
7:48
hologic ceo steve macmillan on breast cancer detection, future of ai-powered diagnostics
-
8:17
text and soft trials
-
2:27
dr. o’shaughnessy on differentiating between cdk 4/6 inhibitors
-
1:17
dr. o'shaughnessy on role of chemotherapy in future tnbc treatment
-
4:54
understanding the extenet trial
-
0:49
dr. o'shaughnessy describes the school of breast oncology
-
2:01
dr. o'shaughnessy discusses new developments in molecular profiling in breast cancer
-
2:20
fact or fiction w/dr. o: er breast cancer and soy
-
1:44
dr. o'shaughnessy discusses negative tnbc iniparib trial results
-
1:11
joyce o’shaughnessy, md: candidacy for eribulin therapy
-
2:04
dr. joyce o’shaughnessy on promising agents in triple-negative breast cancer
-
1:28
dr. o'shaughnessy on precision medicine in triple negative breast cancer